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Abstract
Background
Quick Sequential Organ Failure Assessment (qSOFA) is a three-item clinical instrument
for bedside identification of sepsis patients at risk of poor outcome. qSOFA could be a
valuable triage tool in emergency departments of low-income countries, yet its performance
in resource-limited settings remains unknown. The prognostic accuracy of qSOFA for 28-
day all-cause mortality in febrile adults treated at the EDs in a low-income country was
evaluated.
Methods
Retrospective analysis of a prospective cohort study of consecutive patients (18 years)
with fever (tympanic temperature38˚C and fever7 days) who presented between July
2013 and May 2014 at four emergency departments in Dar es Salaam, Tanzania. Medical
history, clinical examination, laboratory and microbiological data were collected to document
the cause of fever. Variables for the previous and new sepsis criteria were collected at inclu-
sion and qSOFA, SOFA and SIRS were measured at inclusion. Patients were followed up
by phone at day 28. The performance (sensitivity, specificity and area under the receiver
operating curve [AUROC]) of qSOFA (score2), SOFA (increase of2 points) and SIRS
(2 criteria) as predictors of 28-day all-cause mortality was evaluated.
Results
Among the 519 patients (median age: 30 years) included in the analysis, 47% were female
and 25% were HIV positive. Overall, 85% had a microbiologically and/or clinically
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documented infection and 15% a fever of unknown origin. The most common site and
causes of infections were the respiratory tract (43%), dengue (26%), malaria (6%) and
typhoid fever (5%). Twenty-eight-day all-cause mortality was 6%: 3% for patients with a
qSOFA <2 and 24% for those with a score2 (absolute difference, 21%; 95% CI 12%-
31%). The prognostic accuracy of qSOFA (AUROC 0.80, 95% CI 0.73–0.87) for 28-day
mortality was similar to SOFA (AUROC 0.79, 0.71–0.87; p = 0.1) and better than SIRS
(AUROC 0.61, 0.52–0.71; p<0.001).
Conclusions
Among patients with fever at emergency departments in Tanzania, qSOFA had a prognostic
accuracy for 28-day mortality comparable to SOFA and superior to SIRS. These results sup-
port the use of qSOFA as a triage tool to identify patients with sepsis and at risk of poor out-
come in resource-limited countries.
Trial registration
Clinicaltrials.gov Identifier: NCT01947075
Introduction
Fever is a frequent medical condition leading to health care seeking and hospital admission
[1–3]. Identification of patients with fever who have or are at risk of sepsis is a challenge in
emergency departments, especially in low-income countries where resources are limited in
term of healthcare workers and laboratory facilities. Early recognition of sepsis patients is criti-
cal as prompt initiation of appropriate therapy improves survival [4, 5].
Together with the publication of the Third International Consensus Definitions for Sepsis
and Septic Shock (Sepsis-3) [6], a simplified clinical Sequential (Sepsis-related) Organ Failure
Assessment (SOFA) score coined quick SOFA (qSOFA) derived from and validated in large
clinical data sets, was proposed to help clinicians identify sepsis patients among those with sus-
pected infection [4]. Composed of three easy-to-measure clinical parameters (i.e. Glasgow
coma score, systolic blood pressure and respiratory rate), qSOFA exhibited higher predictive
validity for in-hospital mortality than SOFA and Systemic Inflammatory Response Syndrome
(SIRS) among encounters with suspected infection outside the ICU. In a recent prospective
study conducted in emergency departments of four European countries, qSOFA had greater
prognostic accuracy for in-hospital mortality than SIRS or severe sepsis, but not SOFA [7]. In
other mostly retrospective studies performed in emergency departments, qSOFA was associ-
ated with in-hospital mortality, had an adequate to good predictive accuracy for mortality and
had a low sensitivity but a high specificity to predict mortality [8–12].
On a large American observational study conducted in emergency departments and wards,
commonly used early warning scores such as the Modified Early Warning Score (MEWS) and
the National Early Warning Score (NEWS) were shown to be more accurate than the qSOFA
score for predicting mortality [13]. These scores are more complicated and the NEWS needs
oxygen saturation as a parameter. They have been designed in high-income countries and may
be difficult to apply in a resource-limited environment.
Altogether, there is ample evidence derived from a growing number of studies suggesting
that qSOFA may be a useful triage tool for prompt identification of sepsis patients in
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emergency departments. Given that it is composed of three clinical parameters rapidly and
easily assessable at the bedside, it is a highly attractive instrument to be used in emergency
departments of low-income and resource-limited countries, yet its performance in these set-
tings remains unknown [14].
The objective of the present study was to evaluate the prognostic accuracy of qSOFA for
28-day all-cause mortality in febrile adult patients treated at emergency departments in Dar es
Salaam, Tanzania and to compare it with SOFA and SIRS.
Material and methods
Study design, setting and population
A prospective cohort study to document the etiologies of fever was performed between July 18
2013 and May 14 2014 at the emergency departments of Mwananyamala Regional Hospital
and connected health care facilities (Sinza Hospital, Magomeni Health Centre, Tandale Health
Centre) in Kinondoni, the most populated (1,800,000 inhabitants) district of Dar es Salaam,
the largest city (4,365,000 inhabitants) and economic center of Tanzania. This study gave a
unique opportunity to evaluate qSOFA in this population. All consecutive adult (age18
years) patients presenting with fever (tympanic temperature38.0˚C) at the emergency
departments were prospectively screened for inclusion in the study. The inclusion criteria
were: 1) the presence of a new fever defined as a tympanic temperature38.0˚C lasting for 7
days or less, 2) first consultation for the present problem. Exclusion criteria were: 1) refusal of
HIV testing, 2) injury or trauma as main reason for consultation, 3) hospital admission within
the last month (in order to include community-acquired infections), 4) delivery within 6
weeks. Clinical outcome was assessed by a visit or a phone call on day 7 and by a phone call on
day 28.
Study procedures
Data collection. Demographic characteristics, co-morbidities, symptoms and signs were
collected at inclusion. Blood pressure was measured with an automated device (Omron1 M6).
Laboratory investigations. Complete blood count (Horiba Medical ABX Pentra 80 hema-
tology analyzer), serum alanine transferase and serum creatinine (Biochemical Systems Inter-
national fully automated clinical chemistry analyzer) were measured in all patients. Bilirubin
(Biochemical Systems International fully automated clinical chemistry analyzer) was measured
in a subgroup of patients who were admitted. Blood cultures were drawn on site in all patients
and sent to the research laboratory of Ifakara Health Institute in Bagamoyo, Tanzania. Rapid
diagnostic tests for HIV (Alere Determine™ HIV-1/2, confirmed by Trinity Biotech Uni-gold™
Recombigen1 HIV-1/2), dengue (SD BIOLINE Dengue Duo1), malaria (ICT Malaria P.f.1),
typhoid fever (Reszon Diagnostics International TYPHIDOT Rapid IgM1) were performed
on site on the day of inclusion in all patients. Additional diagnostic tests were performed using
predefined algorithms adapted from a previously published study (S1 Table) [15].
Definitive diagnosis. Sites and causes of infections were established for each patient on
the basis of predefined clinical and microbiological criteria derived from World Health Orga-
nization, Infectious Diseases Society of America guidelines and European Society of Clinical
Microbiology and Infectious Diseases guidelines as defined previously [15]. The diagnostic
workup in the emergency department was done by the study team, but the final decision to
admit a patient was the responsibility of the physician in charge of the hospital ward.
Scores. qSOFA (one point each for systolic hypotension [100 mmHg], tachypnea [22/
min] or altered mentation [Glasgow coma score14]) and SOFA scores as well as SIRS crite-
ria were assessed at inclusion. We used a modified version of the SOFA score developed for
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resource-limited settings, as previously described [16]. SpO2 was used instead of PaO2/FIO2
and the systolic arterial blood pressure instead of the mean arterial blood pressure. For calcula-
tion of the SOFA score, missing values were assumed to be within the normal range (i.e.
assigning a 0 value). Considering that bilirubin was not tested and considered normal in out-
patients, a variable of the SOFA score was missing in 22 patients (9 platelets count, 11 creati-
nine, 5 bilirubin). Dichotomic variables (<2 and2) were generated for every score.
Main outcome and statistical analysis
The outcome was 28-day all-cause mortality. Demographic, clinical, laboratory and scores
characteristics as well as infectious diagnoses of survivors and non-survivors were compared
using Wilcoxon-Mann-Whitney and chi-square tests. The prognostic accuracy of the different
scores to predict 28-day mortality was assessed by comparing the area under the receiver oper-
ating characteristic curve (AUROC) calculated for each score. An AUROC between 0.6 and
0.7 was considered as poor, adequate between 0.7 and 0.8, good between 0.8 and 0.9 and excel-
lent above 0.9 [4]. We also compared the survival rate of patients with less than 2 versus 2
points or more for SOFA and qSOFA scores or with less than 2 versus 2 criteria or more for
SIRS. The diagnostic performances (sensitivity, specificity, negative and positive predictive val-
ues) of qSOFA, SOFA and SIRS were calculated using the same cutoffs. The association
between the categorical variables of qSOFA, SOFA and SIRS and 28-day all-cause mortality
was evaluated by stratified analyses. The sample size of the study, which was primarily con-
ducted to identify the causes of fever, guarantees a power of 70% to detect an absolute increase
in mortality of 10% in patients with a qSOFA score of 2 or more compared to the overall base-
line mortality rate which was fixed at 6% according to our data [6]. All analyses were per-
formed with STATA software (version 12, Stata Corp, College Station, TX, USA). Differences
were considered as statistically significant with a two-sided P value of less than 0.05.
Ethical considerations
All participants consented in writing to participation in this research. The Ifakara Health Insti-
tute Review Board (IHI/IRB/No: 12–2013), the Medical Research Coordinating Committee of
the National Institute for Medical Research (NIMR/HQ/R.8a/Vol. IX/1561) of Tanzania and
the Ethics Committee of the canton of Basel of Switzerland (Ref. Nr. EK: 1612/13) gave ethical
clearance.
Results
A total of 641 patients with fever were prospectively enrolled in the study and assessed for eligi-
bility. After exclusion of 41 patients due to hospitalization in the last month, 31 to HIV screen-
ing refusal, 16 to fever for more than 7 days, 16 because their main complaint was an injury or
trauma, 11 because it was not their first consultation for the present symptoms and 7 because
they were within 6 weeks of delivery, 519 patients were included in the analyses (Fig 1).
Among 16022 patients attending the outpatient clinic of the hospitals, including consultations
for chronic diseases, who were screened for the presence of fever between the 23rd of Septem-
ber 2013 (data not available during the first two months of the study) and the end of recruit-
ment on May 14th 2014, 556 (3.5%) had documented fever.
Characteristics of the study population are shown in Table 1. The median age was 30 years,
47% were females and the HIV prevalence was 25%. Among the 519 included patients, 441
(85%) had a microbiologically (positive result of any kind of laboratory test aiming at detecting
a pathogen (culture, molecular, serology, rapid diagnostic test)) or clinically documented
infection and 78 (15%) an unknown cause of fever. Among these 441 patients with
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documented infection, 628 diagnoses were clinically and/or microbiologically identified.
Among patients with a clinically-documented infection, the sites of infection were the respira-
tory tract (N = 223; 43%), the genito-urinary tract (N = 38; 7%), the abdomen (N = 31; 6%),
the central nervous system (N = 5; 1%), the skin (N = 2; 0.4%) and the skeletal system (N = 1;
0.2%). Among patients with a microbiologically-documented infection, most common diag-
noses were dengue (N = 134; 26%), malaria (N = 29; 6%) and typhoid fever (N = 28; 5%).
Overall, 210 (40%) patients received antibiotics following a pre-defined management algo-
rithm and 16% were admitted to the hospital. Fifteen percent of patients had a qSOFA of 2 or
higher, 30% a SOFA of 2 or higher and 82% a SIRS of 2 or higher. Nine (1.7%) patients died
within 2 days, 18 (3.5%) within 7 days and 32 (6.2%) within 28 days. Among the 32 non-survi-
vors, 42 infectious diagnoses were established (12 acute respiratory infections, 6 fevers of
unknown origin, 5 cryptococcal infections, 4 tuberculosis, 4 gastroenteritis, 3 urinary tract
infections, 2 dengue, 1 meningitis, 1 measles, 1 malaria, 1 primary bacteremia (Streptococcus
pyogenes), 1 non-streptococcal pharyngitis, 1 diabetic foot infection). Among patients who
died within 28 days, one was not admitted, 25 died in the hospital after a mean of 6 days (SD
6) and six died after a mean of 8 days (SD 7) after hospital discharge. Patients who died were
older (median age of 41 versus 29 years; p<0.001), were more often HIV-infected (56% versus
23%; p<0.001), were mainly recruited in hospitals and not in healthcare centers (94% versus
64%; p = 0.001) and were less often infected by dengue virus (6 versus 27%; p = 0.01) (Table 1).
Hospital admission rates and 28-day all-cause mortality according to qSOFA, SOFA and
SIRS are reported in Table 2. Mortality was 3% for patients with a qSOFA score of less than 2
and 24% for those with a score of 2 or more (absolute difference, 21%; 95% CI 12–31%;
p<0.001). It was 3% for patients with an increase of SOFA score of less than 2 points and 15%
for those with an increase of more than 2 points (absolute difference, 12%; 95% CI 7–18%;
p<0.001). In contrast, the mortality rate was not significantly different between patients who
Fig 1. Flowchart of eligible patients and exclusion criteria.
https://doi.org/10.1371/journal.pone.0197982.g001
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Table 1. Baseline characteristics of study participants according to survival at day 28.
All
N = 519
Day 28 non-survivors
N = 32
Day 28 survivors
N = 487
No. (%) or Median (IQR) p-value
Age, years 30 (23–40) 41 (28–49) 29 (23–39) <0.001
Female sex 246 (47%) 19 (59%) 227 (47%) 0.16
Inclusion in a hospital (versus healthcare center) 343 (66%) 30 (94%) 313 (64%) 0.001
HIV positive 128 (25%) 18 (56%) 110 (23%) <0.001
CD4, cells/mm3 (HIV+ patients) 122 (51–260) 80 (45–148) 127 (59–275) 0.07
Temperature, ˚C 38.3 (38.0–39.0) 38.4 (38.1–38.9) 38.3 (38.0–39.0) 0.63
Systolic blood pressure, mmHg 118 (106–126) 106 (98–120) 119 (106–126) 0.001
Systolic blood pressure100 mmHg 89 (17%) 14 (44%) 75 (15%) <0.001
Respiratory rate, breaths/min 23 (20–26) 28 (26–32) 23 (20–25) <0.001
Respiratory rate22/min 325 (63%) 27 (84%) 298 (61%) 0.01
Heart rate, beats/min 106 (90–119) 126 (111–133) 105 (90–117) <0.001
Glasgow Coma scale score14 17 (3%) 14 (44%) 3 (0.6%) <0.001
Laboratory results
White blood cell count, cells/mL 5.8 (4.2–8.6) 6.4 (5.2–13) 5.8 (4.2–8.5) 0.06
Platelets, 103/μL a 184 (118–252) 181 (85–292) 184 (122–252) 0.66
Creatinine, mg/dL b 0.99 (0.84–1.2) 1.0 (0.80–1.6) 0.99 (0.84–1.2) 0.26
Bilirubin, mg/dL c 0.32 (0.16–0.72) 0.15 (0.08–0.23) 0.34 (0.18–0.81) <0.001
Sites of infection
Respiratory 223 (43%) 18 (56%) 205 (42%) 0.12
Genito-urinary 38 (7%) 3 (9%) 35 (7%) 0.65
Abdominal 31 (6%) 4 (13%) 27 (6%) 0.11
Other sites 8 (2%) 5 (16%) 3 (0.6%) <0.001
Most common microbiologically documented infections
Dengue 134 (26%) 2 (6%) 132 (27%) 0.01
Malaria 29 (6%) 0 (0) 29 (6%) 0.16
Typhoid 28 (5%) 0 (0) 28 (6%) 0.16
SIRS 0.21
0 30 (6%) 0 (0) 30 (6%)
1 65 (13%) 3 (9%) 62 (13%)
2 126 (24%) 6 (19%) 120 (25%)
3 215 (41%) 14 (44%) 201 (41%)
4 83 (16%) 9 (28%) 74 (15%)
SIRS2 424 (82%) 29 (91%) 395 (81%) 0.18
SOFA2 d 156 (30%) 23 (72%) 133 (27%) <0.001
qSOFA e <0.001
0 172 (33%) 1 (3%) 171 (35%)
1 268 (52%) 12 (38%) 256 (53%)
2 74 (14%) 14 (44%) 60 (12%)
3 5 (1%) 5 (16%) 0 (0)
qSOFA2 79 (15%) 19 (59%) 60 (12%) <0.001
Management
Antibiotic therapy 210 (41%) 24 (75%) 186 (38%) <0.001
Hospital admission 81 (16%) 31 (97%) 50 (10%) <0.001
(Continued)
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had less than 2 SIRS criteria and those who had 2 and more (absolute difference, 4%; 95% CI
-0.6—+8%, p = 0.18).
Compared to patients with a qSOFA score below 2, those with a score of 2 or greater had a
10-fold odds increased risk in 28-day mortality. Compared to patients with a SOFA score and
a SIRS below 2, those with a score of 2 or greater had 6-fold and a 2-fold odds increase in
28-day mortality, respectively (Table 3). The OR for qSOFA was much lower in HIV positive
(5; 95% CI 2–13) than in HIV negative patients (17; 5–54), which was not the case for SOFA
and SIRS. Stratified analyses by the other factors did not show significant differences.
A qSOFA and SOFA scores of 2 or greater had a sensitivity of 59% and 72% and a specificity
of 88% and 73% for predicting 28-day mortality. The sensitivity of SIRS was higher (91%), but
Table 1. (Continued)
All
N = 519
Day 28 non-survivors
N = 32
Day 28 survivors
N = 487
No. (%) or Median (IQR) p-value
Length of hospital stay f (admitted patients) 4 (2–8) 3 (2–12) 4 (2–7) 0.66
a 9 missing values;
b 11 missing values;
c 329 missing values;
d Considering that bilirubin was not tested and considered normal in outpatients, a variable of the SOFA score was missing in 22 patients (9 platelets count, 11
creatinine, 5 bilirubin);
e Variables for the calculation of qSOFA were available for every patient;
f 1 Length of hospital stay missing.
https://doi.org/10.1371/journal.pone.0197982.t001
Table 2. Hospital admission rate and mortality at day 28 according to scores.
qSOFA score SOFA score SIRS score
<2 points
N = 440
2 points
N = 79
Absolute difference <2 points
N = 363
2 points
N = 156
Absolute difference <2 criteria
N = 95
2 criteria
N = 424
Absolute difference
No. (%) No. (%) % (95% CI) No. (%) No. (%) % (95% CI) No. (%) No. (%) % (95% CI)
Hospital admission 40 (9) 41 (52) 43 (32–54) 33 (9) 48 (31) 22 (14–30) 6 (6) 75 (18) 11 (5–18)
Day 28 mortality 13 (3) 19 (24) 21 (12–31) 9 (3) 23 (15) 12 (7–18) 3 (3) 29 (7) 4 (-0.6–8)
https://doi.org/10.1371/journal.pone.0197982.t002
Table 3. Diagnostic performances of the different scores using a cut-off or 2 or greater to predict day 28
mortality.
qSOFA SOFA SIRS
Sensitivity, % (95% CI) 59 (41–76) 72 (53–86) 91 (75–98)
Specificity, % (95% CI) 88 (84–91) 73 (69–77) 19 (16–23)
Predictive value, % (95% CI)
Positive 24 (15–35) 15 (9.6–21) 7 (4.6–9.7)
Negative 97 (95–98) 98 (95–99) 97 (91–99)
Likelihood ratio (95% CI)
Positive 4.8 (3.3–7.0) 2.6 (2.0–3.4) 1.1 (1.0–1.3)
Negative 0.5 (0.3–0.7) 0.4 (0.2–0.7) 0.5 (0.2–1.5)
Odds ratio (95% CI) 10 (5–22) 7 (3–15) 2 (0.7–8)
https://doi.org/10.1371/journal.pone.0197982.t003
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the specificity was poor (19%) (Table 3). The negative predictive value for 28-day mortality of
a qSOFA, SOFA and SIRS below 2 was very high for all scores (97, 98 and 97%, respectively).
As shown in Fig 2, the prognostic accuracy for 28-day mortality using qSOFA (AUROC =
0.80; 95% CI 0.73–0.87) and SOFA (0.79; 0.71–0.87) was better than using SIRS (0.61; 0.52–
0.71) (p<0.01 for both pairwise comparisons with SIRS). qSOFA predicted 28-day mortality
better in HIV negative (0.85; 0.76–0.93) than in HIV positive patients (0.72; 0.59–0.84), while
the predictive accuracy of SOFA for 28-day mortality was not affected by HIV status (0.78;
0.67–0.90 in HIV negative and 0.72; 0.59–0.84 in HIV positive patients).
Fig 2. Receiver operating characteristic (ROC) curves for 28-day mortality. SOFA indicates Sequential (Sepsis-related) Organ Failure
Assessment; qSOFA, quick SOFA; SIRS, systemic inflammatory response syndrome. The area under the ROC curves (AUROC) for qSOFA is
0.80 (95% CI 0.73–0.87), SOFA 0.79 (95% CI 0.71–0.87) and SIRS 0.61 (95% CI 0.52–0.71).
https://doi.org/10.1371/journal.pone.0197982.g002
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SIRS predicted 28-day mortality adequately in HIV negative patients (0.72; 0.57–0.87), but
was not predictive of mortality in HIV positive patients (0.48; 0.36–0.61) (S1 Fig).
Discussion
In a large cohort of febrile patients attending emergency departments of a resource-limited
African country with high HIV prevalence, we investigated the prognostic accuracy of qSOFA,
SOFA and SIRS as predictors of 28-day all-cause mortality. Among 519 patients of whom 85%
had a microbiologically or clinically documented infection, qSOFA had a prognostic accuracy
for 28-day mortality similar to that of SOFA but greatly superior to that of SIRS.
The robust prognostic accuracy of qSOFA (AUROC of 0.80) confirms and extends to emer-
gency departments of an African urban environment previous analogous findings with respect
to in-hospital mortality obtained in large North-American and European data sets (AUROC
of 0.81 and 0.80) [4, 7]. Of note, a retrospective study including 329 patients with fever or
hypothermia and SIRS admitted to a hospital (rather than attending the ED as in our study) in
Gabon also showed a good predictive validity of qSOFA for in-hospital mortality with an
AUROC of 0.83 [17]. The characteristics of the patients included in Gabon were similar to
those included in our study with regard to age, sex, HIV prevalence and mortality. In the study
conducted in Gabon, the sample size was limited and the prognostic accuracy of qSOFA could
not be compared to that of SOFA as it was not calculated, nor to that of SIRS as only patients
with 2 or more SIRS criteria were included.
In the present study, 82% of patients had a SIRS of 2 or greater while only 15% had a
qSOFA of 2 or greater. SIRS criteria had a higher sensitivity (91%) compared to qSOFA score
(59%). However, the discriminative value of SIRS score was poor with a very low specificity
compared to qSOFA (19% versus 88%). Importantly, there was no difference in the rate of
false-negatives between qSOFA and SIRS (3.0% versus 3.2%) with a high negative predictive
value for both scores. These results are similar to those found in the study conducted in Euro-
pean emergency departments discussed above which support the use of qSOFA as a triage tool
in emergency departments [7].
Interestingly, the mortality of patients with a SOFA score of 2 or more was 15%, which also
is very well in line with the anticipated overall mortality of around 10% in this subset of
patients according to the new Sepsis-3 definition [6]. In the present study, the mortality rate of
patients with a qSOFA of 2 or greater was 24%, which is the same than the observed mortality
in the prospective European emergency department study [7]. This observation supports the
use of qSOFA as a bedside tool to identify among febrile patients the subgroup of septic
patients with poor outcome. The performance characteristics of qSOFA (intermediate sensitiv-
ity and high specificity) make it an attractive triage instrument to assist clinicians in making
the best use of limited resources.
The performance of qSOFA to predict mortality was much lower in HIV positive patients
while the performance of SOFA was not affected by HIV status. The rate of false negative
qSOFA scores was higher in HIV positive patients compared to HIV negative patients (1.4%
versus 8.5%, p = 0.002). Additional studies including a higher number of HIV infected patients
would help to better understand the performance of the different scores in this specific
population.
This study has several strengths. First, it validates the discriminative power of qSOFA as a
triage tool at emergency departments of a large African city in patients with sepsis due or
related to infections that are quite different (malaria, dengue, typhoid; high HIV prevalence)
from that found in Western countries. Second, it supports the use of qSOFA as a simple and
accurate triage tool in a resource-limited setting in Africa. Indeed, we used the qSOFA
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calculated at admission and not the worse qSOFA value during the stay in the emergency
department. Third, we followed up the patients to have 28-day mortality and not only in-hos-
pital mortality [7]. This is especially relevant in a resource-limited setting where patients are
likely to be discharged early for socio-cultural or economic reasons (median length of hospital
stay of 4 days compared to 7 days in the prospective European emergency department study).
Fourth, we made a lot of efforts to have a precise and broad clinical and microbiological docu-
mentation of infection. One limitation of the present study is that we did not measure lactate.
However, when added to qSOFA in the analysis of large databases of admitted patients as well
as in a cohort study of patients in emergency departments with a suspected infection, it did
not perform better than without lactate [4, 7]. A second limitation is the few data that were
missing to calculate the SOFA score, which may have affected its performance.
Conclusions
Among patients with fever attending emergency departments in Dar es Salaam (urban Tanza-
nia), the performance of qSOFA to predict 28-day mortality was not significantly different
from a more sophisticated, but difficult to obtain SOFA score and it was greatly superior to
SIRS. The qSOFA tool can be easily implemented in low-resource countries as it relies on sim-
ple clinical measurements and can be rapidly calculated at the patient side without the need of
blood tests. These findings support the use of qSOFA as a triage tool in emergency depart-
ments of resource-poor countries to identify patients with infection at higher risk of mortality
who need prompt management and a higher surveillance level. This is particularly critical in
health care settings where patient triage is often done by nurses given the limited number of
medical doctors.
Supporting information
S1 Fig. Receiver operating characteristic (ROC) curves for 28-day mortality in (A) HIV
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